Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995–2015

Abstract

SummaryBackgroundComparable estimates of health spending are crucial for the assessment of health systems and to optimally deploy health resources. The methods used to track health spending continue to evolve, but little is known about the distribution of spending across diseases. We developed improved estimates of health spending by source, including development assistance for health, and, for the first time, estimated HIV/AIDS spending on prevention and treatment and by source of funding, for 188 countries.MethodsWe collected published data on domestic health spending, from 1995 to 2015, from a diverse set of international agencies. We tracked development assistance for health from 1990 to 2017. We also extracted 5385 datapoints about HIV/AIDS spending, between 2000 and 2015, from online databases, country reports, and proposals submitted to multilateral organisations. We used spatiotemporal Gaussian process regression to generate complete and comparable estimates for health and HIV/AIDS spending. We report most estimates in 2017 purchasing-power parity-adjusted dollars and adjust all estimates for the effect of inflation.FindingsBetween 1995 and 2015, global health spending per capita grew at an annualised rate of 3·1% (95% uncertainty interval [UI] 3·1 to 3·2), with growth being largest in upper-middle-income countries (5·4% per capita [UI 5·3–5·5]) and lower-middle-income countries (4·2% per capita [4·2–4·3]). In 2015, $9·7 trillion (9·7 trillion to 9·8 trillion) was spent on health worldwide. High-income countries spent $6·5 trillion (6·4 trillion to 6·5 trillion) or 66·3% (66·0 to 66·5) of the total in 2015, whereas low-income countries spent $70·3 billion (69·3 billion to 71·3 billion) or 0·7% (0·7 to 0·7). Between 1990 and 2017, development assistance for health increased by 394·7% ($29·9 billion), with an estimated $37·4 billion of development assistance being disbursed for health in 2017, of which $9·1 billion (24·2%) targeted HIV/AIDS. Between 2000 and 2015, $562·6 billion (531·1 billion to 621·9 billion) was spent on HIV/AIDS worldwide. Governments financed 57·6% (52·0 to 60·8) of that total. Global HIV/AIDS spending peaked at 49·7 billion (46·2–54·7) in 2013, decreasing to $48·9 billion (45·2 billion to 54·2 billion) in 2015. That year, low-income and lower-middle-income countries represented 74·6% of all HIV/AIDS disability-adjusted life-years, but just 36·6% (34·4 to 38·7) of total HIV/AIDS spending. In 2015, $9·3 billion (8·5 billion to 10·4 billion) or 19·0% (17·6 to 20·6) of HIV/AIDS financing was spent on prevention, and $27·3 billion (24·5 billion to 31·1 billion) or 55·8% (53·3 to 57·9) was dedicated to care and treatment.InterpretationFrom 1995 to 2015, total health spending increased worldwide, with the fastest per capita growth in middle-income countries. While these national disparities are relatively well known, low-income countries spent less per person on health and HIV/AIDS than did high-income and middle-income countries. Furthermore, declines in development assistance for health co...

Predictors of Health Insurance Enrollment among HIV Positive Pregnant Women in Kenya: Potential for Adverse Selection and Implications for HIV Treatment and Prevention

“…In the HIV/AIDS space, tremendous gains have been recorded, with the number of new HIV infections and AIDS-related deaths markedly decreasing since peaking in 1997 and 2005, respectively [3]. These gains are partly the result of focusing on the HIV cascade [4,5] and mobilizing more than US $500 billion in global resources [6]. However, this progress seems to be slowing down.…”

“…Reductions in new HIV infections in the past decade have slowed down, raising concerns of a resurgence, which is compounded by increasing incidences in some 50 countries [7], especially among youths and adolescents [8][9][10]. Global funding for HIV is also beginning to decline steadily [6]. According to the Kaiser Family foundation, donor spending on HIV declined by 13% from US $8.62 billion in 2014 to US $7.53 billion in 2015 [11].…”

“…In Kenya, like most countries in sub-Saharan Africa (SSA), HIV programs are largely dependent on external donor funding. In 2015 for example, Kenya spent US $1.9 billion on HIV/AIDS [6]. Of that total, 15.6% was government HIV/AIDS spending, 2% was prepaid private HIV/AIDS spending, while 10.4% was out-of-pocket (OOP) payments [6].…”

“…In 2015 for example, Kenya spent US $1.9 billion on HIV/AIDS [6]. Of that total, 15.6% was government HIV/AIDS spending, 2% was prepaid private HIV/AIDS spending, while 10.4% was out-of-pocket (OOP) payments [6]. The remaining 72% of HIV spending was from development assistance, with 59.6% going to curative care and 18.6% going to treatment and prevention [6].…”

Mobilizing civil society for the HIV treatment cascade: a global analysis on democracy and its association with people living with HIV who know their status

“…Additionally, we computed the estimated HIV prevalence, in percentage, for each country by dividing the 2016 estimates for total number of PLHIV by the total population of the country, which were obtained from the UNAIDS database and World Bank respectively . Total expenditure on HIV prevention programmes was obtained from a study conducted by the Global Burden of Disease Health Financing Collaborator Network that provided estimates for health spending in the year 2015, which was collected as a continuous variable, in US dollar (USD) millions . Lastly, data on the prevalence of HIV criminalization laws were obtained from the HIV Justice Network, and was collected as a binary, categorical variable (yes vs. no) ; these include HIV‐specific criminals laws that specifically penalize PLHIV who know their status and who intentionally or unintentionally expose others to HIV, or general criminal laws (e.g.…”